Alveo Technologies: Neil Gunn

Alveo has appointed Neil Gunn to its board of directors. Gunn is currently the CEO of IDbyDNA after recently retiring as president of Roche Sequencing Solutions. He will advise on overall business plans for Alveo's be.well at-home infectious disease testing platform.